{"title":"A qualitative study on employment opportunities and social inclusion of persons with mental illness: Lived experiences.","authors":"Sushma Kumari, Manoj Kumar","doi":"10.4103/ipj.ipj_364_24","DOIUrl":"https://doi.org/10.4103/ipj.ipj_364_24","url":null,"abstract":"<p><strong>Background: </strong>Across the Globe, including in India, significant changes have occurred in the Mental health policies, programs, and schemes for Persons With Mental Illness (PWMI). Gradually, people are becoming aware of the nature of mental illness. Many Bollywood actors are coming forward to share their mental health conditions and show how successfully they handle them. Despite all these efforts, even the recovered or recovering PWMI are still being denied their basic fundamental human rights, especially regarding selection and continuation of gainful employment along with social inclusion at the community level.</p><p><strong>Aim: </strong>Considering the above, the present study aimed to understand the lived experiences regarding the opportunities available for employment and social inclusion among PWMI in India.</p><p><strong>Material and methods: </strong>The present study was based on a qualitative design. Patients who maintained well on treatment and had capabilities to be included in gainful employment, but were still facing difficulties in securing and maintaining regular employment, and faced discrimination in social inclusion in society, were assessed in detail by in-depth interviews after obtaining their due consent.</p><p><strong>Results: </strong>The main themes that emerged from the study were related to their own experience of the journey of recovery in terms of getting the opportunity for full participation in employment or to be acknowledged as a valuable person in their society rather than a patient.</p><p><strong>Conclusion: </strong>The present study's findings would enhance the understanding among health professionals, policy-makers, and community persons to plan and develop supportive programs/ social welfare services that treat PWMI as persons and involve them as productive members of society.</p>","PeriodicalId":13534,"journal":{"name":"Industrial Psychiatry Journal","volume":"34 1","pages":"76-81"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077645/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144078046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
George Felix, Manoj K Sharma, Nitin Anand, Binukumar Bhaskarapillai, Kalpana Srivastava
{"title":"Psychometric evaluation of smartphone addiction scale - short version (SAS-SV) among young adults of India.","authors":"George Felix, Manoj K Sharma, Nitin Anand, Binukumar Bhaskarapillai, Kalpana Srivastava","doi":"10.4103/ipj.ipj_336_24","DOIUrl":"https://doi.org/10.4103/ipj.ipj_336_24","url":null,"abstract":"<p><strong>Background: </strong>Although smartphones have considerable utility, they also have addiction potential. The early detection of problematic smartphone use (PSU) can have significant implications for managing its psychosocial consequences. Smartphone Addiction Scale - Short Version (SAS-SV), initially developed for South Korean adolescents, has emerged as a reliable measure for adults across countries. However, SAS-SV continues to be used unvalidated in India.</p><p><strong>Aim: </strong>To evaluate the psychometric properties of SAS-SV for the Indian adult population.</p><p><strong>Materials and methods: </strong>Content validation of SAS-SV was done by 10 experts, followed by data collection for validation using a cross-sectional design from 434 participants (<i>M</i> <sub>age</sub> = 25.4; <i>SD</i> <sub>age</sub> = 2.6; 58.8% females). The datasheet consisted of a sociodemographic questionnaire and SAS-SV. Statistical analyses comprised confirmatory factor analysis (CFA), exploratory factor analysis (EFA), reliability analyses, percentiles, and evaluation of sociodemographic variables.</p><p><strong>Results: </strong>SAS-SV's content validity index was 0.93, and item wordings were adjusted after experts' feedback. CFA did not show good fit indices; hence, EFA was used, which explained 44% of the variance from a unifactorial model. Cronbach's alpha was 0.85, McDonald's Omega was 0.86, and test-retest reliability was 0.81. There were no significant PSU differences in gender, marital status, and occupational status. Higher PSU was associated with lower age, lower education, nuclear family, and more hours of smartphone usage.</p><p><strong>Conclusion: </strong>The current study established the psychometric properties of SAS-SV for the Indian adult population. SAS-SV can be used for assessment and treatment monitoring of PSU.</p>","PeriodicalId":13534,"journal":{"name":"Industrial Psychiatry Journal","volume":"34 1","pages":"53-60"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144077621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Low dose baclofen and standard dose acamprosate had comparable changes in brain glutamate, brain Gamma amino butyric acid (GABA) and craving among patients with alcohol dependence syndrome: A 1H-MRS based open label randomized study.","authors":"Akhil Kesan, Pranjal Dey, Sourav Khanra, Samiksha Singhai, Monalisa Boro","doi":"10.4103/ipj.ipj_187_23","DOIUrl":"https://doi.org/10.4103/ipj.ipj_187_23","url":null,"abstract":"<p><strong>Background: </strong>Understanding of the mechanism of action of Baclofen as anticraving inalcohol dependence syndrome (ADS) is limited.</p><p><strong>Aim: </strong>Our study aimed to examine and compareearly changes in brain glutamate and GABA with Baclofen and Acamprosate among patients with alcohol dependence syndrome.</p><p><strong>Material and methods: </strong>Forty patients with ADS were recruited with purposive sampling and were randomized into two groups using computer-generated randomization. At the end of detoxification (CIWA-Ar <10) brain glutamate and GABA were measured with proton magnetic resonance spectroscopy (1H-MRS) in the anterior cingulate cortex (ACC) of the brain along with a measure of craving (PACS). Either Acamprosate or Baclofen was started. After 25 days of starting Baclofen or Acamprosate brain glutamate and brain GABA using 1H-MRS and PACS measures were repeat measured.</p><p><strong>Results: </strong>Both groups had shown comparable changes in brain glutamate (<i>F</i> = 0.01, <i>P</i> = 0.92, <i>ηp2</i> = 0.00) and GABA (<i>F</i> = 0.29, 26 <i>P</i> = 0.59, <i>ηp2</i> = 0.008) and craving (<i>F</i> = 0.08, <i>P</i> = 0.77, <i>ηp2</i> = 0.002) over time. Baclofen and Acamprosate showed a differential relation with the clinical characteristics of participants.</p><p><strong>Conclusion: </strong>Our study has shown comparable changes in Glutamate and GABA during the early post-detoxification period both for baclofen and acamprosate. Effects of baclofen and acamprosate might correlate differently with the clinical profile of alcohol dependence syndrome which would help in choosing a particular anticraving medication.</p>","PeriodicalId":13534,"journal":{"name":"Industrial Psychiatry Journal","volume":"34 1","pages":"25-31"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077627/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144077424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
V Pooja, Bhushan Chaudhari, Suprakash Chaudhury, Daniel Saldanha
{"title":"Turner's syndrome with schizophrenia: A case report.","authors":"V Pooja, Bhushan Chaudhari, Suprakash Chaudhury, Daniel Saldanha","doi":"10.4103/ipj.ipj_34_23","DOIUrl":"10.4103/ipj.ipj_34_23","url":null,"abstract":"","PeriodicalId":13534,"journal":{"name":"Industrial Psychiatry Journal","volume":" ","pages":"144-145"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077620/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44857745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aaliya Khanam, Rajnish Raj, Zaid A Wani, Yasir H Rather, Iqra Arshad
{"title":"Pregabalin dependence: Experiences from liaison psychiatric settings in Kashmir, North India: A case series.","authors":"Aaliya Khanam, Rajnish Raj, Zaid A Wani, Yasir H Rather, Iqra Arshad","doi":"10.4103/ipj.ipj_474_24","DOIUrl":"https://doi.org/10.4103/ipj.ipj_474_24","url":null,"abstract":"<p><p>Pregabalin, a gamma-aminobutyric acid (GABA) analog, is a new-generation antiepileptic that is approved for the treatment of neuropathic pain, fibromyalgia, partial seizures, and generalized anxiety disorder. There is a rising concern regarding its abuse potential, and a handful of case reports have highlighted the same. We present a case series on pregabalin dependence. In contrast to previous case reports, which focused on patients with a history of illicit drug abuse, we present cases of drug-naïve individuals for whom pregabalin was the first substance of abuse. The highlight of the study is that we describe cases of pregabalin intoxication and a rare case of pregabalin withdrawal, which presented as a lethal suicidal attempt to liaison psychiatric settings.</p>","PeriodicalId":13534,"journal":{"name":"Industrial Psychiatry Journal","volume":"34 1","pages":"114-116"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144077614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Artificial intelligence in psychiatric education: Enhancing clinical competence through simulation.","authors":"Victor Ajluni","doi":"10.4103/ipj.ipj_377_24","DOIUrl":"https://doi.org/10.4103/ipj.ipj_377_24","url":null,"abstract":"<p><p>The integration of artificial intelligence (AI) in psychiatric education offers transformative potential to enhance clinical competence through realistic simulations. Traditional educational methods face limitations in replicating complex psychiatric cases, and AI-based tools provide a scalable solution. This narrative review examines current evidence on the efficacy of AI-powered simulations, focusing on their role in skill development, diagnostic accuracy, and safe clinical training. Through a comprehensive literature review of studies from 2010 to 2024, key themes such as AI's ability to standardize patient encounters, provide instant feedback, and improve student confidence are explored. Findings suggest that AI can enhance psychiatric education by offering consistent, adaptable learning experiences that prepare trainees for real-world complexities. However, challenges such as ethical considerations and accessibility disparities must be addressed for AI to be effectively integrated into psychiatric training. This review provides insights into the future of AI in medical education and its potential impact on training the next generation of psychiatrists.</p>","PeriodicalId":13534,"journal":{"name":"Industrial Psychiatry Journal","volume":"34 1","pages":"11-15"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144078050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Classifying opioid use disorder based on diagnostic criteria items using cluster analysis.","authors":"Shweta Birla, Vinit Patel, Dinesh Gupta, Rishi Gupta, Yatan Pal Singh Balhara, Siddharth Sarkar","doi":"10.4103/ipj.ipj_430_24","DOIUrl":"https://doi.org/10.4103/ipj.ipj_430_24","url":null,"abstract":"<p><strong>Background: </strong>Opioid use disorder (OUD) is a global concern with a reported shift in changing demographic and biopsychosocial profiles. Characterization of clusters based on diagnostic symptom criteria can help to understand the underlying associations between these criteria.</p><p><strong>Aim: </strong>The present study identifies clusters based on OUD diagnostic criteria, which may reveal clinically relevant subgroups of individuals with OUDs.</p><p><strong>Materials and methods: </strong>The DSM5 diagnostic system OUD diagnosis was made for 204 male participants. An unsupervised clustering analysis focused on the individual 11 DSM5 diagnostic criteria.</p><p><strong>Results: </strong>Using the DSM5 diagnostic criteria, we obtained two clusters based on severity. Further, analyzing clinical information along with DSM5 criteria, two groups varying in OUD severity, presence of injecting drug use, and employment were identified.</p><p><strong>Conclusion: </strong>Based on cluster analysis, two main clusters of DSM5 criteria emerged. Rather than DSM5 symptoms clustering with each other based on the similarity of symptomatology, they aggregate numerically reflecting severity.</p>","PeriodicalId":13534,"journal":{"name":"Industrial Psychiatry Journal","volume":"34 1","pages":"32-38"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077617/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144078055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alishba Hameed, Hamna Noor, Muhammad Abdullah Ali, Zaryab Bacha, Umama Alam, Sidra Irfan
{"title":"Exploring the interplay between anxiety and academic procrastination: An institution-based cross-sectional study from Pakistan.","authors":"Alishba Hameed, Hamna Noor, Muhammad Abdullah Ali, Zaryab Bacha, Umama Alam, Sidra Irfan","doi":"10.4103/ipj.ipj_383_24","DOIUrl":"https://doi.org/10.4103/ipj.ipj_383_24","url":null,"abstract":"<p><strong>Background: </strong>Procrastination, the unnecessary delay of tasks, is common among college students, especially in academic settings. Academic procrastination often leads to last-minute rushes and increased anxiety. The relationship between procrastination and anxiety is intricate, complicating the determination of which triggers the other.</p><p><strong>Aim: </strong>To examine how anxiety and procrastination interact among medical students, particularly focusing on their reciprocal influence.</p><p><strong>Materials and methods: </strong>This descriptive cross-sectional study included 311 MBBS students, recruited through simple convenient sampling. Procrastination was assessed with the Irrational Procrastination Scale (IPS) and anxiety with the Generalized Anxiety Disorder 7-item (GAD-7) scale. Data analysis was conducted using SPSS version 27, with Chi-square tests, Pearson correlation, and linear regression. Statistical significance was set at <i>P</i> < 0.05.</p><p><strong>Results: </strong>Pearson correlation showed a significant, weak positive correlation between anxiety and procrastination (r = 0.346, <i>P</i> < .001). Subcategories of the IPS correlated with anxiety from negligible to high. Chi-square analysis found a significant association of anxiety with procrastination (<i>P</i> < 0.001) and gender (<i>P</i> = 0.038), but no significant link of anxiety or procrastination with the year of study was observed. Linear regression revealed that anxiety significantly predicted procrastination (B = 0.354, <i>P</i> < 0.05) and vice versa (B = 0.339, <i>P</i> < 0.05), explaining 12% of the variance.</p><p><strong>Conclusion: </strong>The study found a weak yet significant positive correlation between anxiety and procrastination, indicating that the relationship might be bidirectional. However, the cross-sectional design and reliance on self-reported data highlight the need for further longitudinal research to better understand these dynamics.</p>","PeriodicalId":13534,"journal":{"name":"Industrial Psychiatry Journal","volume":"34 1","pages":"82-88"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144078073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Julio Torales, Iván Barrios, Alejandra Echagüe, Ximena Paredes, Anthon Torres-Romero, Karina Malvido, María Alejandra Vázquez, Marcelo O'Higgins, Tomás Caycho-Rodríguez, Mohammad Jafferany, João Mauricio Castaldelli-Maia, Antonio Ventriglio
{"title":"Knowledge and awareness in psychodermatology: Findings from a survey among Ibero-Latin American dermatologists.","authors":"Julio Torales, Iván Barrios, Alejandra Echagüe, Ximena Paredes, Anthon Torres-Romero, Karina Malvido, María Alejandra Vázquez, Marcelo O'Higgins, Tomás Caycho-Rodríguez, Mohammad Jafferany, João Mauricio Castaldelli-Maia, Antonio Ventriglio","doi":"10.4103/ipj.ipj_388_24","DOIUrl":"https://doi.org/10.4103/ipj.ipj_388_24","url":null,"abstract":"<p><strong>Background: </strong>Psychodermatology is an interdisciplinary field that bridges psychiatry and dermatology, addressing the psychosocial and psychiatric aspects of skin diseases. Managing such cases presents a challenge for both dermatologists and psychiatrists as patients often resist psychiatric consultations, complicating diagnosis and treatment.</p><p><strong>Aim: </strong>This study aimed to assess the level of knowledge and awareness of psychodermatology among dermatologists in Ibero-Latin America, explore their experiences with psychodermatological conditions, and identify the educational needs and challenges in this interdisciplinary field.</p><p><strong>Materials and methods: </strong>An observational, descriptive, cross-sectional study was conducted through an online survey from December 2023 to March 2024. The survey was distributed through messaging apps and emails and targeted a sample of dermatologists from Ibero-Latin America to explore their experience, training, and perceived challenges in psychodermatology. The participants were selected through non-probabilistic sampling from the staffing records of the Ibero-Latin American College of Dermatology.</p><p><strong>Results: </strong>Of 301 dermatologists, the vast majority (99%) reported a good level of knowledge in the field of psychodermatology; however, only 36.5% had substantial clinical experience with these conditions. Approximately 70.1% did not prescribe psychotropic medications, reflecting hesitancy or lack of confidence in managing the psychiatric issues of dermatological conditions. The study also highlighted a strong preference (86.7%) for a multidisciplinary approach for managing psychodermatological disorders. Significant perceived challenges included limited access to professional training and patients' reluctance to accept psychological contributions to their dermatological conditions.</p><p><strong>Conclusion: </strong>The level of knowledge in psychodermatology is widespread among Ibero-Latin American dermatologists, even though a significant gap in practical experience and confidence in integrating psychological management into their dermatological practice was found. These findings emphasize the need for enhanced professional training programs and an interdisciplinary approach to effectively address psychodermatological conditions.</p>","PeriodicalId":13534,"journal":{"name":"Industrial Psychiatry Journal","volume":"34 1","pages":"16-24"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077646/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144077422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}